One year of treatment with the targeted drug olaparib improves long-term survival in women with high-risk, early-stage breast ...

Ahead of the AACR-San Antonio Breast Cancer Symposium, we caught up with two ICR researchers and their supervisor to find out ...

Scientists have developed a machine learning tool that can predict how an aggressive type of breast cancer will respond to ...

Researchers at the ICR co-led a recent study showing that it is possible to reverse drug resistance and slow tumour progression in prostate cancer by targeting myeloid white blood cells. Tumours can ...

Alex Naim, 27, a solution engineer living in London, completed the Royal Parks Half Marathon and raised thousands of pounds for our vital research, even though running is one of his least favourite ...

Dr Jessica May Hislop joined The Institute of Cancer Research as a Bioinformatician in the Houlston Lab in the Genetics and Epidemiology division. Together with her colleagues, she is working towards ...

Jesse was two years old when he was diagnosed with B-cell acute lymphoblastic leukaemia, a type of blood and bone marrow cancer, in November 2023. Now, a year since his diagnosis and thankfully in ...

Dr Jessica May Hislop joined the Institute of Cancer Research (ICR) as a Bioinformatician in the Houlston Lab in the Genetics and Epidemiology division. Together with her colleagues, she is working ...

Jesse was two years old when he was diagnosed with B-cell acute lymphoblastic leukaemia, a type of blood and bone marrow cancer, in November 2023. Now, a year since his diagnosis and thankfully in ...

Natalie Pearce, 52, was diagnosed with stage 3c ovarian cancer in November 2012. She subsequently discovered she carries the BRCA1 gene mutation, putting her at a higher risk of developing various ...

Projects for the 2024/2025 PhD studentships are below. You will also find a link to further information about our application process, our application portal and mailing list, should you wish to be ...

Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Video: ICR Chief Executive Kristian Helin gives an overview ...